瘤免疫微环境中的甲基化:多维机制和向治疗策略
Senxu Lu1, Junxiu Liu2, Shixin Chen1
1Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, China; Orthopedics Research Institute of Zhejiang University, Hangzhou, Zhejiang 310000, China; Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou, Zhejiang 310000, China.
Biochimica et biophysica acta. Reviews on cancer
|October 31, 2025
概括
N6-甲基氨酸 (m6A) 修饰调节基因表达并影响瘤免疫学. 本综述探讨了瘤和免疫细胞中的m6A如何塑造瘤微环境,并提出了新的免疫治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- N6-甲基氨酸 (m6A) 是一种动态RNA修饰,对基因表达调节至关重要.
- m6A在瘤细胞和免疫系统之间的复杂相互作用中发挥着重要作用.
- 了解m6A在瘤免疫学中的作用对于开发新型癌症疗法至关重要.
研究的目的:
- 在瘤免疫学中审查m6A甲基化的调节机制.
- 阐明瘤和免疫细胞中的m6A修饰如何影响瘤免疫微环境.
- 提出创新的治疗策略,将针对性与免疫疗法结合起来.
主要方法:
- 文献综述专注于m6癌症免疫学中的一种修改.
- 分析m6A对免疫检查点,信号通路和细胞因子分泌的影响.
- 检查m6A的免疫相关基因的直接调节.
主要成果:
- 瘤细胞内部的一些修改重新编程了瘤免疫微环境.
- 免疫细胞内的一些修改也塑造了免疫微环境.
- m6A影响免疫检查点,信号通路和细胞因子分泌.
结论:
- m6甲基化是瘤免疫学的关键调节剂.
- 向m6A为癌症免疫治疗提供了有前途的治疗途径.
- 对M6A机制的进一步研究可以解锁新的治疗策略.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


